(BLSA) 2026 to recognise excellence in scientific research, innovation, and public health impact across India's life sciences ecosystem. Backed by Rs 7 crore in grant support, the Award is instituted to recognise outstanding scientists, research institutions, universities, startups, and ecosystem leaders advancing healthcare and life sciences. This initiative is organised by FICCI with Lilly and supported by the Office of the Principal Scientific Adviser to the Government of India, Department of Pharmaceuticals, Biotechnology Industry Research Assistance Council (BIRAC) & Invest India.
The Award comprises six honours across five categories, covering individual excellence, collaborative innovation, institutional excellence, healthcare and life sciences startups and scientific ecosystem development. While four categories carry grant support, two categories recognise outstanding contributions to innovation and ecosystem building. Applications will be evaluated by an independent jury through a transparent assessment process.
Applications are open from 1 July to 10 August 2026 and no application fee is required. Researchers, scientists, public research institutions, universities, private sector innovators can participate. For eligibility details and online applications, visit www.bharatlifesciencesawards.com.
The six honours span individual research, collaborative innovation, institutional work, startups and development of the wider scientific ecosystem. Four award categories include grant support, while two recognise contributions to innovation and ecosystem building without being described as grant-bearing categories.
Applications are open from 1 July to 10 August and carry no application fee. The organisers say an independent jury will assess entries, making the published eligibility rules and assessment process important documents for researchers, universities, public institutions and private innovators considering an application.
The organising partnership brings together FICCI and Lilly with support from the Principal Scientific Adviser's office, the Department of Pharmaceuticals, BIRAC and Invest India. Applicants should distinguish the organisers and supporting institutions from the independent jury that will evaluate submissions.
